Alnylam Pharmaceuticals, Inc.

Maryland State Retirement & Pension System ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

6,346

Value ($000)

2,523

Weight

0.1%

2020 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	2,523	0.1%	6,346	12/31/2025
2025 Q3	10/29/2025	2,821	0.1%	6,186	9/30/2025
2025 Q2	7/23/2025	1,963	0.0%	6,021	6/30/2025
2025 Q1	5/12/2025	1,626	0.0%	6,021	3/31/2025
2024 Q4	2/11/2025	1,645	0.0%	6,990	12/31/2024
2024 Q3	11/12/2024	1,978	0.0%	7,193	9/30/2024
2024 Q2	7/30/2024	2,390	0.0%	9,836	6/30/2024
2024 Q1	4/19/2024	1,441	0.0%	9,836	3/31/2024
2023 Q4	2/6/2024	1,809	0.0%	9,451	12/31/2023
2023 Q3	10/24/2023	1,674	0.0%	9,451	9/30/2023
2023 Q2	7/11/2023	1,795	0.0%	9,451	6/30/2023
2023 Q1	4/20/2023	1,936	0.0%	9,665	3/31/2023
2022 Q4	1/18/2023	2,297	0.1%	9,665	12/31/2022
2022 Q3	10/28/2022	1,873	0.2%	9,360	9/30/2022
2022 Q2	8/1/2022	1,327	0.0%	9,099	6/30/2022
2022 Q1	4/11/2022	1,486	0.0%	9,099	3/31/2022
2021 Q4	2/9/2022	1,543	0.0%	9,099	12/31/2021
2021 Q3	10/29/2021	1,617	0.0%	8,827	9/30/2021
2021 Q2	7/13/2021	1,539	0.1%	8,827	6/30/2021
2021 Q1	5/10/2021	1,246	0.0%	8,827	3/31/2021
2020 Q4	2/4/2021	288	0.1%	1,862	12/31/2020